| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/23/2009 | US20090186928 3-[1-(4-Chlorophenyl)-trans-3-fluorocyclobutyl]-4,5-dicyclopropyl-r-4H-1,2,4-triazole anhydrate; Type 2 diabetes, hyperglycemia, obesity, dyslipidemia, hypertension, and cognitive impairment |
| 07/23/2009 | US20090186927 Trans-9,10-dehydroepothilone c and d, analogs thereof and methods of making the same |
| 07/23/2009 | US20090186926 Self-Emulsifying Formulations of CETP Inhibitors |
| 07/23/2009 | US20090186925 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
| 07/23/2009 | US20090186924 Substituted arylpyrazoles |
| 07/23/2009 | US20090186923 Compounds Having CRTH2 Antagonist Activity |
| 07/23/2009 | US20090186922 2-arylindole derivatives as npges-i inhibitors |
| 07/23/2009 | US20090186921 Azacyclic compounds |
| 07/23/2009 | US20090186920 Sulfonamides as orexin antagonists |
| 07/23/2009 | US20090186919 Piperidine derivatives for treatment of alzheimer's disease |
| 07/23/2009 | US20090186918 Triazole Compounds as Lipoxygenase Inhibitors |
| 07/23/2009 | US20090186917 6-And 7-amino isoquinoline compounds and methods for making and using the same |
| 07/23/2009 | US20090186916 Aminoindane derivative or salt thereof |
| 07/23/2009 | US20090186915 Compositions and methods for treatment of glioblastoma, gliosarcoma, NSCLC, and head and neck cancer |
| 07/23/2009 | US20090186914 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 07/23/2009 | US20090186913 Tetrahalogenated compounds useful as inhibitors of angiogenesis |
| 07/23/2009 | US20090186912 Anti-infective agents and uses thereof |
| 07/23/2009 | US20090186911 (RS)-S-[3-({[6-Bromo-4-(isopropylamino)quinazolin-7-yl]oxy}methyl)phenyl] N-(ethoxycarbonyl)-S-ethylsulphoximide, used for the treatment of chronic inflammatory diseases, such as rheumatoid arthritis, Crohn's disease, asthma and multiple sclerosis |
| 07/23/2009 | US20090186910 Compositions and methods for reducing cellular fat and for predicting cardiac toxicity and upon treatment with tyrosine kinase inhibitors |
| 07/23/2009 | US20090186909 Oxadiazolidinedione Compound |
| 07/23/2009 | US20090186908 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 07/23/2009 | US20090186907 Pyrazinones As Cellular Proliferation Inhibitors |
| 07/23/2009 | US20090186906 N-((S)-4,4-dimethyl-1-oxo-1-((3aS,6aR)-3-oxo-dihydro-2H-furo[3,2-b]pyrrol-4(5H6H, 6aH)-yl)pentan-2-yl)-4-(4-methylpiperazin-1-yl)benzamide; treatment of a disease selected from osteoporosis, Paget's disease, Chagas's disease, malaria, gingival diseases, hypercalaemia, metabolic bone disease, bone cancer |
| 07/23/2009 | US20090186905 Anaplastic lymphoma kinase modulators and methods of use |
| 07/23/2009 | US20090186904 Substituted Oxindole Derivatives, Medicaments Containing the Latter and Use Thereof |
| 07/23/2009 | US20090186903 Aripiprazole complex formulation and method |
| 07/23/2009 | US20090186902 Substituted Tetrahydroimidazopyridine Compounds and the Use Thereof in the Treatment of Pain and Other Conditions |
| 07/23/2009 | US20090186901 Chemical compounds |
| 07/23/2009 | US20090186900 Compound |
| 07/23/2009 | US20090186899 Substituted Sulfonamide Compounds |
| 07/23/2009 | US20090186898 Inhibitors of bruton's tyrosine kinase |
| 07/23/2009 | US20090186897 Phthalazinone derivatives |
| 07/23/2009 | US20090186896 PDE Inhibitors and Combinations Thereof for the Treatment of Urological Disorders |
| 07/23/2009 | US20090186895 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 07/23/2009 | US20090186894 N-Substituted-Heterocycloalkyloxybenzamide Compounds and Methods of Use |
| 07/23/2009 | US20090186893 inositol requiring enzyme 1 (IRE-1 alpha) inhibitors such as 2-hydroxy-6-(5-(4-methylpiperazine-1-carbonyl)thiophen-2-yl)-1-naphthaldehyde, relieve protein folding stress by enhancing molecular chaperone activity and protects cells from stress induced apoptosis; autoimmune diseases; anticancer; viricides |
| 07/23/2009 | US20090186892 Methods for treating lung cancers |
| 07/23/2009 | US20090186891 Organic compounds |
| 07/23/2009 | US20090186890 Pharmaceutical Formulation of Iressa Comprising a Water-Soluble Cellulose Derivative |
| 07/23/2009 | US20090186889 Spiro-substituted pyrrolopyrimidines |
| 07/23/2009 | US20090186888 Novel fused pyrrolocarbazoles |
| 07/23/2009 | US20090186887 Novel pyrimidothienoindazoles |
| 07/23/2009 | US20090186886 Tricyclic 1,2,4-Triazine Oxides and Compositions for Therapeutic Use in Cancer Treatments |
| 07/23/2009 | US20090186885 Therapeutic compounds |
| 07/23/2009 | US20090186884 such as N-(3-amino-2-hydroxypropyl)-3-(1-(2-(2-ethylphenoxy)phenyl)-1-hydroxy-5-;methoxypentyl)piperidine-1-carboxamide, used for the treatment of cardiovascular disorders |
| 07/23/2009 | US20090186883 Stable Aqueous Suspension |
| 07/23/2009 | US20090186882 Cgrp receptor antagonists |
| 07/23/2009 | US20090186881 1(R)-1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-[4-(tetrahydropyran-4-yl)-piperazin-1-yl]-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl); calcitonin gene related peptide antagonist; analgesic, antidiabetic agent; migraine or cluster headaches, non-insulin-dependent diabetes |
| 07/23/2009 | US20090186880 Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use |
| 07/23/2009 | US20090186879 Tricyclic compounds and use thereof |
| 07/23/2009 | US20090186878 Crystalline forms of a farnesyl dibenzodiazepinone |
| 07/23/2009 | US20090186877 Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors |
| 07/23/2009 | US20090186876 Pyridine Analogues II |
| 07/23/2009 | US20090186875 Dihydrothienopyrimidines, suitable for the treatment of respiratory, gastrointestinal, inflammatory, nervous system disorders and/or cancer |
| 07/23/2009 | US20090186874 Carboxamide derivative and use thereof |
| 07/23/2009 | US20090186873 3-Fluoro-4-[4-[2-(3,5-dimethylphenyl)pyrrolidin-1-yl-methyl]phenoxy]benzamide for treating alcoholism, ethanol use disorder withdrawal, and anxiety and/or depression, or schizophrenia |
| 07/23/2009 | US20090186872 Loxapine analogs and methods of use thereof |
| 07/23/2009 | US20090186871 Tyrosine kinase inhibitors |
| 07/23/2009 | US20090186870 Therapeutic Agents - 802 |
| 07/23/2009 | US20090186869 Antiviral compounds |
| 07/23/2009 | US20090186868 Taxane Compound Having Azetidine Ring Structure |
| 07/23/2009 | US20090186867 Substituted Diketopiperazines As Oxytocin Antagonists |
| 07/23/2009 | US20090186866 Therapeutic beta-lactams |
| 07/23/2009 | US20090186865 Lyophilization Process |
| 07/23/2009 | US20090186864 Ruthenium (ii) compounds |
| 07/23/2009 | US20090186863 Use of cholest-4-en-3-one derivatives for obtaining a cytoprotective drug |
| 07/23/2009 | US20090186862 Treatment of cystic fibrosis |
| 07/23/2009 | US20090186861 Process for Production of Fatty Acids, Fatty Acid Esters and Sterolesters from Soapstock |
| 07/23/2009 | US20090186859 Diazeniumdiolated non-steroidal anti-inflammatory drugs, compositions thereof, and related methods |
| 07/23/2009 | US20090186857 Combretastatin A-4 Phosphate Prodrug Mono- and Di- Organic Amine Salts, Mono- and Di- Amino Acid Salts, and Mono- and Di- Amino Acid Ester Salts |
| 07/23/2009 | US20090186856 Micronutrient phosphates as dietary and health supplements |
| 07/23/2009 | US20090186855 antagonists; oligopeptide of N-(3-indolylacetyl)-L-isoleucine and glycine; IBD, sepsis, periodontal disease, mucositis, acne, cardiovascular disease, COPD, arthritis, cystic fibrosis, infections, ischemia/reperfusion, asthma, stroke, brain injuries, enterocolitis, bed sores, leprosy, atopic dermatitis |
| 07/23/2009 | US20090186854 S-alkylisothiouronium derivatives for the treatment of inflammatory diseases |
| 07/23/2009 | US20090186853 Compositions comprising n-propanoyl derivatives of amino acids, aminocarbohydrates and derivatives thereof |
| 07/23/2009 | US20090186852 Tri- and tetra-oligo-saccharides suitable as agglutination agents for enteric pathogens |
| 07/23/2009 | US20090186851 Hemostatic material |
| 07/23/2009 | US20090186850 Peritoneal dialysis method |
| 07/23/2009 | US20090186849 Antisense antiviral compounds and methods for treating a filovirus infection |
| 07/23/2009 | US20090186848 Antisense antiviral compounds and methods for treating a filovirus infection |
| 07/23/2009 | US20090186847 Antisense antiviral compounds and methods for treating a filovirus infection |
| 07/23/2009 | US20090186845 Interfering rna molecules |
| 07/23/2009 | US20090186844 SiRNA DELIVERY INTO MAMMALIAN NERVE CELLS |
| 07/23/2009 | US20090186843 RNA sequence-specific mediators of RNA interference |
| 07/23/2009 | US20090186842 Methods and compositions for inhibition of viral replication |
| 07/23/2009 | US20090186841 Novel aminoglycoside antibiotics |
| 07/23/2009 | US20090186840 5-Thioxylopyranose Compounds |
| 07/23/2009 | US20090186839 Model for studying the role of genes in chemoresistance |
| 07/23/2009 | US20090186838 Amphotericin Derivatives |
| 07/23/2009 | US20090186837 Anti-neoplastic compositions comprising extracts of black cohosh |
| 07/23/2009 | US20090186836 Method for neutralizing fungi using sophorolipids and antifungal sophorolipids for use therein |
| 07/23/2009 | US20090186835 Treatment and prophylaxis of cancer |
| 07/23/2009 | US20090186834 Diphenylheterocycle cholesterol absorption inhibitors |
| 07/23/2009 | US20090186833 Method for producing pectin hydrolysis products |
| 07/23/2009 | US20090186832 Amino acid peptide pro-drugs of phenolic analgesics and uses thereof |
| 07/23/2009 | US20090186829 Nitrosation-Inducible Inhibitors Biological Macromolecules |
| 07/23/2009 | US20090186828 Abuse-resistant amphetamine prodrugs |
| 07/23/2009 | US20090186825 Abuse-resistant amphetamine prodrugs |
| 07/23/2009 | US20090186818 Therapeutic Method for Glycaemic Control |
| 07/23/2009 | US20090186816 Polypeptide targeting to mitochondria |
| 07/23/2009 | US20090186815 Identification of jak/stat pathway modulating genes by genome wide rnai screening |